newsfilter
← Latest News
Business Wire·

Taysha Gene Therapies Added to the ICE Biotechnology Index

Taysha Gene Therapies, Inc. (NASDAQ:TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare